C4 article: Implications of COVID-19 in transplantation.

Journal Article (Journal Article)

A novel coronavirus has had global impact on individual health and health care delivery. In this C4 article, contributors discuss various aspects of transplantation including donor and recipient screening, management of infected patients, and prevention of coronavirus disease (COVID). Donor screening with SARS-CoV-2 nucleic acid testing (NAT) close to the time of procurement is recommended. Many programs are also screening all potential recipients at the time of admission. The management of COVID has evolved with remdesivir emerging as a new potential option for transplant recipients. Dexamethasone has also shown promise and convalescent plasma is under study. Prevention strategies for transplant candidates and recipients are paramount. Pediatric-specific issues are also discussed. Strategies for the psychological well-being of patients and providers are also imperative, in addition to future research priorities for transplantation.

Full Text

Duke Authors

Cited Authors

  • Contributors to the C4 article,

Published Date

  • May 1, 2021

Published In

Volume / Issue

  • 21 / 5

Start / End Page

  • 1801 - 1815

PubMed ID

  • 33040483

Pubmed Central ID

  • PMC7675506

Electronic International Standard Serial Number (EISSN)

  • 1600-6143

Digital Object Identifier (DOI)

  • 10.1111/ajt.16346


  • eng

Conference Location

  • United States